Back

C-C motif chemokine receptor 2 and phosphodiesterase type 5 inhibition in immune subphenotypes: a step toward personalized treatment for pulmonary arterial hypertension?

Cardiovascular Research

10 June 2025
Organised by: Logo
Read full article
ESC Journals BASIC SCIENCE
You may be interested in
thumbnail
Congress Presentation
Recruitment of CCR5-positive T cells in pulmonary vascular lesions in idiopathic- and connective tissue disease associated- pulmonary arterial hypertension
31 August 2024
thumbnail
Congress Presentation
Efficacy of pulmonary hypertension-targeted drugs for severe chronic thromboembolic pulmonary hypertension
3 September 2019
thumbnail
Congress Presentation
Smooth muscle cell specific ablation of CXCL12 downregulates endothelial CXCR7 leading to defective coronary arteries and cardiac hypertrophy
27 August 2021
thumbnail
Congress Session
From genetic signatures to clinical implications
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources